nodes	percent_of_prediction	percent_of_DWPC	metapath
Iopamidol—Blindness cortical—Cisplatin—esophageal cancer	0.0601	0.0601	CcSEcCtD
Iopamidol—Heart disease congenital—Cisplatin—esophageal cancer	0.0491	0.0491	CcSEcCtD
Iopamidol—Areflexia—Cisplatin—esophageal cancer	0.0419	0.0419	CcSEcCtD
Iopamidol—Venous thrombosis—Carboplatin—esophageal cancer	0.0358	0.0358	CcSEcCtD
Iopamidol—Apprehension—Cisplatin—esophageal cancer	0.0295	0.0295	CcSEcCtD
Iopamidol—Extravasation—Carboplatin—esophageal cancer	0.0221	0.0221	CcSEcCtD
Iopamidol—Guillain-Barre syndrome—Methotrexate—esophageal cancer	0.0214	0.0214	CcSEcCtD
Iopamidol—Dysphasia—Capecitabine—esophageal cancer	0.0191	0.0191	CcSEcCtD
Iopamidol—Meningism—Methotrexate—esophageal cancer	0.0179	0.0179	CcSEcCtD
Iopamidol—Skin necrosis—Cisplatin—esophageal cancer	0.0162	0.0162	CcSEcCtD
Iopamidol—Infarction—Capecitabine—esophageal cancer	0.015	0.015	CcSEcCtD
Iopamidol—Neurotoxicity—Cisplatin—esophageal cancer	0.0146	0.0146	CcSEcCtD
Iopamidol—Meningitis aseptic—Methotrexate—esophageal cancer	0.0132	0.0132	CcSEcCtD
Iopamidol—Arterial thrombosis—Methotrexate—esophageal cancer	0.0115	0.0115	CcSEcCtD
Iopamidol—Neurotoxicity—Capecitabine—esophageal cancer	0.0108	0.0108	CcSEcCtD
Iopamidol—Venous thrombosis—Cisplatin—esophageal cancer	0.0105	0.0105	CcSEcCtD
Iopamidol—Blindness—Cisplatin—esophageal cancer	0.0102	0.0102	CcSEcCtD
Iopamidol—Chest tightness—Capecitabine—esophageal cancer	0.0089	0.0089	CcSEcCtD
Iopamidol—Anuria—Methotrexate—esophageal cancer	0.0089	0.0089	CcSEcCtD
Iopamidol—Skin necrosis—Methotrexate—esophageal cancer	0.0089	0.0089	CcSEcCtD
Iopamidol—Peripheral coldness—Capecitabine—esophageal cancer	0.00877	0.00877	CcSEcCtD
Iopamidol—Transient ischaemic attack—Capecitabine—esophageal cancer	0.00827	0.00827	CcSEcCtD
Iopamidol—Neurotoxicity—Methotrexate—esophageal cancer	0.00802	0.00802	CcSEcCtD
Iopamidol—Venous thrombosis—Capecitabine—esophageal cancer	0.00774	0.00774	CcSEcCtD
Iopamidol—Sneezing—Capecitabine—esophageal cancer	0.00754	0.00754	CcSEcCtD
Iopamidol—Necrosis—Cisplatin—esophageal cancer	0.00722	0.00722	CcSEcCtD
Iopamidol—Infection—Carboplatin—esophageal cancer	0.00684	0.00684	CcSEcCtD
Iopamidol—Haematoma—Capecitabine—esophageal cancer	0.00664	0.00664	CcSEcCtD
Iopamidol—Nephropathy—Methotrexate—esophageal cancer	0.00653	0.00653	CcSEcCtD
Iopamidol—Neck stiffness—Methotrexate—esophageal cancer	0.00653	0.00653	CcSEcCtD
Iopamidol—Extravasation—Cisplatin—esophageal cancer	0.00649	0.00649	CcSEcCtD
Iopamidol—Aphasia—Capecitabine—esophageal cancer	0.00644	0.00644	CcSEcCtD
Iopamidol—Nuchal rigidity—Methotrexate—esophageal cancer	0.00599	0.00599	CcSEcCtD
Iopamidol—Hearing impaired—Cisplatin—esophageal cancer	0.00595	0.00595	CcSEcCtD
Iopamidol—Pain—Carboplatin—esophageal cancer	0.00589	0.00589	CcSEcCtD
Iopamidol—Wheezing—Cisplatin—esophageal cancer	0.0055	0.0055	CcSEcCtD
Iopamidol—Ventricular fibrillation—Capecitabine—esophageal cancer	0.00545	0.00545	CcSEcCtD
Iopamidol—Body temperature increased—Carboplatin—esophageal cancer	0.00545	0.00545	CcSEcCtD
Iopamidol—Skin exfoliation—Cisplatin—esophageal cancer	0.00541	0.00541	CcSEcCtD
Iopamidol—Hyperaesthesia—Capecitabine—esophageal cancer	0.00532	0.00532	CcSEcCtD
Iopamidol—Tingling sensation—Capecitabine—esophageal cancer	0.00519	0.00519	CcSEcCtD
Iopamidol—Myocardial ischaemia—Capecitabine—esophageal cancer	0.00519	0.00519	CcSEcCtD
Iopamidol—Injection site pain—Capecitabine—esophageal cancer	0.00511	0.00511	CcSEcCtD
Iopamidol—Petechiae—Capecitabine—esophageal cancer	0.00508	0.00508	CcSEcCtD
Iopamidol—Extrasystoles—Capecitabine—esophageal cancer	0.00496	0.00496	CcSEcCtD
Iopamidol—Eye irritation—Capecitabine—esophageal cancer	0.00489	0.00489	CcSEcCtD
Iopamidol—Aphasia—Methotrexate—esophageal cancer	0.00479	0.00479	CcSEcCtD
Iopamidol—Chest discomfort—Capecitabine—esophageal cancer	0.00472	0.00472	CcSEcCtD
Iopamidol—Musculoskeletal stiffness—Capecitabine—esophageal cancer	0.00465	0.00465	CcSEcCtD
Iopamidol—Ventricular extrasystoles—Capecitabine—esophageal cancer	0.00462	0.00462	CcSEcCtD
Iopamidol—Deafness—Cisplatin—esophageal cancer	0.0046	0.0046	CcSEcCtD
Iopamidol—Lacrimation increased—Capecitabine—esophageal cancer	0.00453	0.00453	CcSEcCtD
Iopamidol—Nasal congestion—Cisplatin—esophageal cancer	0.00451	0.00451	CcSEcCtD
Iopamidol—Paralysis—Methotrexate—esophageal cancer	0.00447	0.00447	CcSEcCtD
Iopamidol—Burning sensation—Methotrexate—esophageal cancer	0.00447	0.00447	CcSEcCtD
Iopamidol—Cyanosis—Methotrexate—esophageal cancer	0.00439	0.00439	CcSEcCtD
Iopamidol—Hearing impaired—Capecitabine—esophageal cancer	0.00439	0.00439	CcSEcCtD
Iopamidol—Amnesia—Cisplatin—esophageal cancer	0.00438	0.00438	CcSEcCtD
Iopamidol—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00425	0.00425	CcSEcCtD
Iopamidol—Neck pain—Capecitabine—esophageal cancer	0.00423	0.00423	CcSEcCtD
Iopamidol—Stupor—Methotrexate—esophageal cancer	0.00416	0.00416	CcSEcCtD
Iopamidol—Depressed level of consciousness—Capecitabine—esophageal cancer	0.00403	0.00403	CcSEcCtD
Iopamidol—Skin exfoliation—Capecitabine—esophageal cancer	0.00399	0.00399	CcSEcCtD
Iopamidol—Face oedema—Cisplatin—esophageal cancer	0.00397	0.00397	CcSEcCtD
Iopamidol—Necrosis—Methotrexate—esophageal cancer	0.00396	0.00396	CcSEcCtD
Iopamidol—Irritability—Cisplatin—esophageal cancer	0.00392	0.00392	CcSEcCtD
Iopamidol—Petechiae—Methotrexate—esophageal cancer	0.00378	0.00378	CcSEcCtD
Iopamidol—Cramp muscle—Cisplatin—esophageal cancer	0.0037	0.0037	CcSEcCtD
Iopamidol—Apnoea—Methotrexate—esophageal cancer	0.00367	0.00367	CcSEcCtD
Iopamidol—Extravasation—Methotrexate—esophageal cancer	0.00356	0.00356	CcSEcCtD
Iopamidol—Thrombophlebitis—Capecitabine—esophageal cancer	0.0035	0.0035	CcSEcCtD
Iopamidol—Musculoskeletal stiffness—Methotrexate—esophageal cancer	0.00346	0.00346	CcSEcCtD
Iopamidol—Sweating increased—Cisplatin—esophageal cancer	0.00346	0.00346	CcSEcCtD
Iopamidol—Swelling—Capecitabine—esophageal cancer	0.00344	0.00344	CcSEcCtD
Iopamidol—Deafness—Capecitabine—esophageal cancer	0.00339	0.00339	CcSEcCtD
Iopamidol—Oliguria—Methotrexate—esophageal cancer	0.00337	0.00337	CcSEcCtD
Iopamidol—Hot flush—Capecitabine—esophageal cancer	0.00324	0.00324	CcSEcCtD
Iopamidol—Amnesia—Capecitabine—esophageal cancer	0.00323	0.00323	CcSEcCtD
Iopamidol—Menopausal symptoms—Capecitabine—esophageal cancer	0.00321	0.00321	CcSEcCtD
Iopamidol—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00312	0.00312	CcSEcCtD
Iopamidol—Renal failure—Cisplatin—esophageal cancer	0.00311	0.00311	CcSEcCtD
Iopamidol—Myocardial infarction—Cisplatin—esophageal cancer	0.00311	0.00311	CcSEcCtD
Iopamidol—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00311	0.00311	CcSEcCtD
Iopamidol—Cardiac failure—Capecitabine—esophageal cancer	0.00311	0.00311	CcSEcCtD
Iopamidol—Conjunctivitis—Cisplatin—esophageal cancer	0.00308	0.00308	CcSEcCtD
Iopamidol—Pain in extremity—Capecitabine—esophageal cancer	0.00303	0.00303	CcSEcCtD
Iopamidol—Depressed level of consciousness—Methotrexate—esophageal cancer	0.003	0.003	CcSEcCtD
Iopamidol—Skin exfoliation—Methotrexate—esophageal cancer	0.00297	0.00297	CcSEcCtD
Iopamidol—Face oedema—Capecitabine—esophageal cancer	0.00293	0.00293	CcSEcCtD
Iopamidol—Bradycardia—Cisplatin—esophageal cancer	0.0029	0.0029	CcSEcCtD
Iopamidol—Irritability—Capecitabine—esophageal cancer	0.00289	0.00289	CcSEcCtD
Iopamidol—Cardiac arrest—Capecitabine—esophageal cancer	0.00288	0.00288	CcSEcCtD
Iopamidol—Urinary retention—Capecitabine—esophageal cancer	0.00288	0.00288	CcSEcCtD
Iopamidol—Ataxia—Capecitabine—esophageal cancer	0.00285	0.00285	CcSEcCtD
Iopamidol—Coma—Methotrexate—esophageal cancer	0.00284	0.00284	CcSEcCtD
Iopamidol—Pulmonary oedema—Methotrexate—esophageal cancer	0.00277	0.00277	CcSEcCtD
Iopamidol—Visual impairment—Cisplatin—esophageal cancer	0.00274	0.00274	CcSEcCtD
Iopamidol—Muscular weakness—Capecitabine—esophageal cancer	0.00267	0.00267	CcSEcCtD
Iopamidol—Tinnitus—Cisplatin—esophageal cancer	0.00265	0.00265	CcSEcCtD
Iopamidol—Flushing—Cisplatin—esophageal cancer	0.00264	0.00264	CcSEcCtD
Iopamidol—Asthma—Capecitabine—esophageal cancer	0.00262	0.00262	CcSEcCtD
Iopamidol—Thrombophlebitis—Methotrexate—esophageal cancer	0.00261	0.00261	CcSEcCtD
Iopamidol—Bronchospasm—Capecitabine—esophageal cancer	0.00258	0.00258	CcSEcCtD
Iopamidol—Sweating increased—Capecitabine—esophageal cancer	0.00255	0.00255	CcSEcCtD
Iopamidol—Angina pectoris—Capecitabine—esophageal cancer	0.00255	0.00255	CcSEcCtD
Iopamidol—Arrhythmia—Cisplatin—esophageal cancer	0.00254	0.00254	CcSEcCtD
Iopamidol—Neutropenia—Capecitabine—esophageal cancer	0.00245	0.00245	CcSEcCtD
Iopamidol—Visual disturbance—Methotrexate—esophageal cancer	0.00238	0.00238	CcSEcCtD
Iopamidol—Muscle spasms—Cisplatin—esophageal cancer	0.00238	0.00238	CcSEcCtD
Iopamidol—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00233	0.00233	CcSEcCtD
Iopamidol—Tremor—Cisplatin—esophageal cancer	0.00232	0.00232	CcSEcCtD
Iopamidol—Acute coronary syndrome—Capecitabine—esophageal cancer	0.0023	0.0023	CcSEcCtD
Iopamidol—Ill-defined disorder—Cisplatin—esophageal cancer	0.0023	0.0023	CcSEcCtD
Iopamidol—Renal failure—Capecitabine—esophageal cancer	0.0023	0.0023	CcSEcCtD
Iopamidol—Myocardial infarction—Capecitabine—esophageal cancer	0.00229	0.00229	CcSEcCtD
Iopamidol—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00229	0.00229	CcSEcCtD
Iopamidol—Conjunctivitis—Capecitabine—esophageal cancer	0.00227	0.00227	CcSEcCtD
Iopamidol—Malaise—Cisplatin—esophageal cancer	0.00223	0.00223	CcSEcCtD
Iopamidol—Haematuria—Capecitabine—esophageal cancer	0.00223	0.00223	CcSEcCtD
Iopamidol—Irritability—Methotrexate—esophageal cancer	0.00215	0.00215	CcSEcCtD
Iopamidol—Convulsion—Cisplatin—esophageal cancer	0.00215	0.00215	CcSEcCtD
Iopamidol—Bradycardia—Capecitabine—esophageal cancer	0.00213	0.00213	CcSEcCtD
Iopamidol—Ataxia—Methotrexate—esophageal cancer	0.00212	0.00212	CcSEcCtD
Iopamidol—Myalgia—Cisplatin—esophageal cancer	0.00211	0.00211	CcSEcCtD
Iopamidol—Haemoglobin—Capecitabine—esophageal cancer	0.00211	0.00211	CcSEcCtD
Iopamidol—Rhinitis—Capecitabine—esophageal cancer	0.0021	0.0021	CcSEcCtD
Iopamidol—Anxiety—Cisplatin—esophageal cancer	0.0021	0.0021	CcSEcCtD
Iopamidol—Haemorrhage—Capecitabine—esophageal cancer	0.0021	0.0021	CcSEcCtD
Iopamidol—Hypoaesthesia—Capecitabine—esophageal cancer	0.00209	0.00209	CcSEcCtD
Iopamidol—Discomfort—Cisplatin—esophageal cancer	0.00208	0.00208	CcSEcCtD
Iopamidol—Anaphylactic shock—Cisplatin—esophageal cancer	0.00202	0.00202	CcSEcCtD
Iopamidol—Visual impairment—Capecitabine—esophageal cancer	0.00202	0.00202	CcSEcCtD
Iopamidol—Infection—Cisplatin—esophageal cancer	0.00201	0.00201	CcSEcCtD
Iopamidol—Tachycardia—Cisplatin—esophageal cancer	0.00197	0.00197	CcSEcCtD
Iopamidol—Tinnitus—Capecitabine—esophageal cancer	0.00196	0.00196	CcSEcCtD
Iopamidol—Hyperhidrosis—Cisplatin—esophageal cancer	0.00195	0.00195	CcSEcCtD
Iopamidol—Asthma—Methotrexate—esophageal cancer	0.00195	0.00195	CcSEcCtD
Iopamidol—Flushing—Capecitabine—esophageal cancer	0.00195	0.00195	CcSEcCtD
Iopamidol—Anorexia—Cisplatin—esophageal cancer	0.00193	0.00193	CcSEcCtD
Iopamidol—Hypotension—Cisplatin—esophageal cancer	0.00189	0.00189	CcSEcCtD
Iopamidol—Chills—Capecitabine—esophageal cancer	0.00188	0.00188	CcSEcCtD
Iopamidol—Arrhythmia—Capecitabine—esophageal cancer	0.00187	0.00187	CcSEcCtD
Iopamidol—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00184	0.00184	CcSEcCtD
Iopamidol—Neutropenia—Methotrexate—esophageal cancer	0.00182	0.00182	CcSEcCtD
Iopamidol—Paraesthesia—Cisplatin—esophageal cancer	0.00181	0.00181	CcSEcCtD
Iopamidol—Dyspnoea—Cisplatin—esophageal cancer	0.0018	0.0018	CcSEcCtD
Iopamidol—Dysgeusia—Capecitabine—esophageal cancer	0.00179	0.00179	CcSEcCtD
Iopamidol—Back pain—Capecitabine—esophageal cancer	0.00177	0.00177	CcSEcCtD
Iopamidol—Decreased appetite—Cisplatin—esophageal cancer	0.00176	0.00176	CcSEcCtD
Iopamidol—Muscle spasms—Capecitabine—esophageal cancer	0.00175	0.00175	CcSEcCtD
Iopamidol—Pain—Cisplatin—esophageal cancer	0.00173	0.00173	CcSEcCtD
Iopamidol—Tremor—Capecitabine—esophageal cancer	0.00171	0.00171	CcSEcCtD
Iopamidol—Renal failure—Methotrexate—esophageal cancer	0.00171	0.00171	CcSEcCtD
Iopamidol—Ill-defined disorder—Capecitabine—esophageal cancer	0.00169	0.00169	CcSEcCtD
Iopamidol—Conjunctivitis—Methotrexate—esophageal cancer	0.00169	0.00169	CcSEcCtD
Iopamidol—Sweating—Methotrexate—esophageal cancer	0.00167	0.00167	CcSEcCtD
Iopamidol—Feeling abnormal—Cisplatin—esophageal cancer	0.00167	0.00167	CcSEcCtD
Iopamidol—Haematuria—Methotrexate—esophageal cancer	0.00166	0.00166	CcSEcCtD
Iopamidol—Malaise—Capecitabine—esophageal cancer	0.00165	0.00165	CcSEcCtD
Iopamidol—Syncope—Capecitabine—esophageal cancer	0.00164	0.00164	CcSEcCtD
Iopamidol—Loss of consciousness—Capecitabine—esophageal cancer	0.0016	0.0016	CcSEcCtD
Iopamidol—Body temperature increased—Cisplatin—esophageal cancer	0.0016	0.0016	CcSEcCtD
Iopamidol—Cough—Capecitabine—esophageal cancer	0.00159	0.00159	CcSEcCtD
Iopamidol—Hypertension—Capecitabine—esophageal cancer	0.00158	0.00158	CcSEcCtD
Iopamidol—Haemoglobin—Methotrexate—esophageal cancer	0.00157	0.00157	CcSEcCtD
Iopamidol—Haemorrhage—Methotrexate—esophageal cancer	0.00156	0.00156	CcSEcCtD
Iopamidol—Chest pain—Capecitabine—esophageal cancer	0.00155	0.00155	CcSEcCtD
Iopamidol—Myalgia—Capecitabine—esophageal cancer	0.00155	0.00155	CcSEcCtD
Iopamidol—Anxiety—Capecitabine—esophageal cancer	0.00155	0.00155	CcSEcCtD
Iopamidol—Discomfort—Capecitabine—esophageal cancer	0.00154	0.00154	CcSEcCtD
Iopamidol—Visual impairment—Methotrexate—esophageal cancer	0.0015	0.0015	CcSEcCtD
Iopamidol—Confusional state—Capecitabine—esophageal cancer	0.0015	0.0015	CcSEcCtD
Iopamidol—Infection—Capecitabine—esophageal cancer	0.00148	0.00148	CcSEcCtD
Iopamidol—Shock—Capecitabine—esophageal cancer	0.00147	0.00147	CcSEcCtD
Iopamidol—Tinnitus—Methotrexate—esophageal cancer	0.00146	0.00146	CcSEcCtD
Iopamidol—Tachycardia—Capecitabine—esophageal cancer	0.00145	0.00145	CcSEcCtD
Iopamidol—Asthenia—Cisplatin—esophageal cancer	0.00145	0.00145	CcSEcCtD
Iopamidol—Hyperhidrosis—Capecitabine—esophageal cancer	0.00144	0.00144	CcSEcCtD
Iopamidol—Anorexia—Capecitabine—esophageal cancer	0.00142	0.00142	CcSEcCtD
Iopamidol—Chills—Methotrexate—esophageal cancer	0.0014	0.0014	CcSEcCtD
Iopamidol—Hypotension—Capecitabine—esophageal cancer	0.00139	0.00139	CcSEcCtD
Iopamidol—Diarrhoea—Cisplatin—esophageal cancer	0.00138	0.00138	CcSEcCtD
Iopamidol—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00136	0.00136	CcSEcCtD
Iopamidol—Paraesthesia—Capecitabine—esophageal cancer	0.00134	0.00134	CcSEcCtD
Iopamidol—Dysgeusia—Methotrexate—esophageal cancer	0.00133	0.00133	CcSEcCtD
Iopamidol—Dyspnoea—Capecitabine—esophageal cancer	0.00133	0.00133	CcSEcCtD
Iopamidol—Back pain—Methotrexate—esophageal cancer	0.00131	0.00131	CcSEcCtD
Iopamidol—Dyspepsia—Capecitabine—esophageal cancer	0.00131	0.00131	CcSEcCtD
Iopamidol—Decreased appetite—Capecitabine—esophageal cancer	0.0013	0.0013	CcSEcCtD
Iopamidol—Vomiting—Cisplatin—esophageal cancer	0.00128	0.00128	CcSEcCtD
Iopamidol—Fatigue—Capecitabine—esophageal cancer	0.00128	0.00128	CcSEcCtD
Iopamidol—Rash—Cisplatin—esophageal cancer	0.00127	0.00127	CcSEcCtD
Iopamidol—Pain—Capecitabine—esophageal cancer	0.00127	0.00127	CcSEcCtD
Iopamidol—Dermatitis—Cisplatin—esophageal cancer	0.00127	0.00127	CcSEcCtD
Iopamidol—Ill-defined disorder—Methotrexate—esophageal cancer	0.00126	0.00126	CcSEcCtD
Iopamidol—Feeling abnormal—Capecitabine—esophageal cancer	0.00123	0.00123	CcSEcCtD
Iopamidol—Malaise—Methotrexate—esophageal cancer	0.00123	0.00123	CcSEcCtD
Iopamidol—Nausea—Cisplatin—esophageal cancer	0.0012	0.0012	CcSEcCtD
Iopamidol—Cough—Methotrexate—esophageal cancer	0.00119	0.00119	CcSEcCtD
Iopamidol—Urticaria—Capecitabine—esophageal cancer	0.00118	0.00118	CcSEcCtD
Iopamidol—Abdominal pain—Capecitabine—esophageal cancer	0.00118	0.00118	CcSEcCtD
Iopamidol—Body temperature increased—Capecitabine—esophageal cancer	0.00118	0.00118	CcSEcCtD
Iopamidol—Convulsion—Methotrexate—esophageal cancer	0.00118	0.00118	CcSEcCtD
Iopamidol—Chest pain—Methotrexate—esophageal cancer	0.00116	0.00116	CcSEcCtD
Iopamidol—Myalgia—Methotrexate—esophageal cancer	0.00116	0.00116	CcSEcCtD
Iopamidol—Discomfort—Methotrexate—esophageal cancer	0.00114	0.00114	CcSEcCtD
Iopamidol—Confusional state—Methotrexate—esophageal cancer	0.00112	0.00112	CcSEcCtD
Iopamidol—Anaphylactic shock—Methotrexate—esophageal cancer	0.00111	0.00111	CcSEcCtD
Iopamidol—Infection—Methotrexate—esophageal cancer	0.0011	0.0011	CcSEcCtD
Iopamidol—Hyperhidrosis—Methotrexate—esophageal cancer	0.00107	0.00107	CcSEcCtD
Iopamidol—Asthenia—Capecitabine—esophageal cancer	0.00107	0.00107	CcSEcCtD
Iopamidol—Anorexia—Methotrexate—esophageal cancer	0.00106	0.00106	CcSEcCtD
Iopamidol—Pruritus—Capecitabine—esophageal cancer	0.00105	0.00105	CcSEcCtD
Iopamidol—Hypotension—Methotrexate—esophageal cancer	0.00104	0.00104	CcSEcCtD
Iopamidol—Diarrhoea—Capecitabine—esophageal cancer	0.00102	0.00102	CcSEcCtD
Iopamidol—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00101	0.00101	CcSEcCtD
Iopamidol—Paraesthesia—Methotrexate—esophageal cancer	0.000996	0.000996	CcSEcCtD
Iopamidol—Dyspnoea—Methotrexate—esophageal cancer	0.000989	0.000989	CcSEcCtD
Iopamidol—Dizziness—Capecitabine—esophageal cancer	0.000985	0.000985	CcSEcCtD
Iopamidol—Dyspepsia—Methotrexate—esophageal cancer	0.000976	0.000976	CcSEcCtD
Iopamidol—Decreased appetite—Methotrexate—esophageal cancer	0.000964	0.000964	CcSEcCtD
Iopamidol—Fatigue—Methotrexate—esophageal cancer	0.000956	0.000956	CcSEcCtD
Iopamidol—Pain—Methotrexate—esophageal cancer	0.000948	0.000948	CcSEcCtD
Iopamidol—Vomiting—Capecitabine—esophageal cancer	0.000947	0.000947	CcSEcCtD
Iopamidol—Rash—Capecitabine—esophageal cancer	0.000939	0.000939	CcSEcCtD
Iopamidol—Dermatitis—Capecitabine—esophageal cancer	0.000938	0.000938	CcSEcCtD
Iopamidol—Headache—Capecitabine—esophageal cancer	0.000933	0.000933	CcSEcCtD
Iopamidol—Feeling abnormal—Methotrexate—esophageal cancer	0.000914	0.000914	CcSEcCtD
Iopamidol—Nausea—Capecitabine—esophageal cancer	0.000885	0.000885	CcSEcCtD
Iopamidol—Urticaria—Methotrexate—esophageal cancer	0.000881	0.000881	CcSEcCtD
Iopamidol—Body temperature increased—Methotrexate—esophageal cancer	0.000877	0.000877	CcSEcCtD
Iopamidol—Abdominal pain—Methotrexate—esophageal cancer	0.000877	0.000877	CcSEcCtD
Iopamidol—Asthenia—Methotrexate—esophageal cancer	0.000796	0.000796	CcSEcCtD
Iopamidol—Pruritus—Methotrexate—esophageal cancer	0.000785	0.000785	CcSEcCtD
Iopamidol—Diarrhoea—Methotrexate—esophageal cancer	0.000759	0.000759	CcSEcCtD
Iopamidol—Dizziness—Methotrexate—esophageal cancer	0.000733	0.000733	CcSEcCtD
Iopamidol—Vomiting—Methotrexate—esophageal cancer	0.000705	0.000705	CcSEcCtD
Iopamidol—Rash—Methotrexate—esophageal cancer	0.000699	0.000699	CcSEcCtD
Iopamidol—Dermatitis—Methotrexate—esophageal cancer	0.000699	0.000699	CcSEcCtD
Iopamidol—Headache—Methotrexate—esophageal cancer	0.000695	0.000695	CcSEcCtD
Iopamidol—Nausea—Methotrexate—esophageal cancer	0.000659	0.000659	CcSEcCtD
